Eintrag weiter verarbeiten
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
Gespeichert in:
Zeitschriftentitel: | Molecular Cancer |
---|---|
Personen und Körperschaften: | , , , , , |
In: | Molecular Cancer, 9, 2010, 1 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Springer Science and Business Media LLC
|
Schlagwörter: |
author_facet |
Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta |
---|---|
author |
Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta |
spellingShingle |
Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta Molecular Cancer Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 Cancer Research Oncology Molecular Medicine |
author_sort |
xu, yong zhong |
spelling |
Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta 1476-4598 Springer Science and Business Media LLC Cancer Research Oncology Molecular Medicine http://dx.doi.org/10.1186/1476-4598-9-210 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec> Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 Molecular Cancer |
doi_str_mv |
10.1186/1476-4598-9-210 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc2LTQ1OTgtOS0yMTA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc2LTQ1OTgtOS0yMTA |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
Springer Science and Business Media LLC, 2010 |
imprint_str_mv |
Springer Science and Business Media LLC, 2010 |
issn |
1476-4598 |
issn_str_mv |
1476-4598 |
language |
English |
mega_collection |
Springer Science and Business Media LLC (CrossRef) |
match_str |
xu2010brg1mediatestheconstitutiveandfenretinideinducedexpressionofsparcinmammarycarcinomacellsviaitsinteractionwithtranscriptionfactorsp1 |
publishDateSort |
2010 |
publisher |
Springer Science and Business Media LLC |
recordtype |
ai |
record_format |
ai |
series |
Molecular Cancer |
source_id |
49 |
title |
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_unstemmed |
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_full |
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_fullStr |
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_full_unstemmed |
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_short |
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_sort |
brg-1 mediates the constitutive and fenretinide-induced expression of sparc in mammary carcinoma cells via its interaction with transcription factor sp1 |
topic |
Cancer Research Oncology Molecular Medicine |
url |
http://dx.doi.org/10.1186/1476-4598-9-210 |
publishDate |
2010 |
physical |
|
description |
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec> |
container_issue |
1 |
container_start_page |
0 |
container_title |
Molecular Cancer |
container_volume |
9 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792340282027540488 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:01:08.018Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Brg-1+mediates+the+constitutive+and+fenretinide-induced+expression+of+SPARC+in+mammary+carcinoma+cells+via+its+interaction+with+transcription+factor+Sp1&rft.date=2010-12-01&genre=article&issn=1476-4598&volume=9&issue=1&jtitle=Molecular+Cancer&atitle=Brg-1+mediates+the+constitutive+and+fenretinide-induced+expression+of+SPARC+in+mammary+carcinoma+cells+via+its+interaction+with+transcription+factor+Sp1&aulast=Radzioch&aufirst=Danuta&rft_id=info%3Adoi%2F10.1186%2F1476-4598-9-210&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792340282027540488 |
author | Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta |
author_facet | Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta, Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta |
author_sort | xu, yong zhong |
container_issue | 1 |
container_start_page | 0 |
container_title | Molecular Cancer |
container_volume | 9 |
description | <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec> |
doi_str_mv | 10.1186/1476-4598-9-210 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc2LTQ1OTgtOS0yMTA |
imprint | Springer Science and Business Media LLC, 2010 |
imprint_str_mv | Springer Science and Business Media LLC, 2010 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 1476-4598 |
issn_str_mv | 1476-4598 |
language | English |
last_indexed | 2024-03-01T16:01:08.018Z |
match_str | xu2010brg1mediatestheconstitutiveandfenretinideinducedexpressionofsparcinmammarycarcinomacellsviaitsinteractionwithtranscriptionfactorsp1 |
mega_collection | Springer Science and Business Media LLC (CrossRef) |
physical | |
publishDate | 2010 |
publishDateSort | 2010 |
publisher | Springer Science and Business Media LLC |
record_format | ai |
recordtype | ai |
series | Molecular Cancer |
source_id | 49 |
spelling | Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta 1476-4598 Springer Science and Business Media LLC Cancer Research Oncology Molecular Medicine http://dx.doi.org/10.1186/1476-4598-9-210 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec> Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 Molecular Cancer |
spellingShingle | Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta, Molecular Cancer, Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1, Cancer Research, Oncology, Molecular Medicine |
title | Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_full | Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_fullStr | Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_full_unstemmed | Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_short | Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
title_sort | brg-1 mediates the constitutive and fenretinide-induced expression of sparc in mammary carcinoma cells via its interaction with transcription factor sp1 |
title_unstemmed | Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 |
topic | Cancer Research, Oncology, Molecular Medicine |
url | http://dx.doi.org/10.1186/1476-4598-9-210 |